Drugs in Dev. Dermatology
Phase III
Italy 
Lead Product(s) : Clascoterone
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The study demonstrated that Clascoterone cream 1%, has favorable long-term safety for the treatment of acne with low rates of treatment related adverse events (AEs).
Product Name : Winlevi
Product Type : Steroid
Upfront Cash : Inapplicable
June 23, 2020
Lead Product(s) : Clascoterone
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
